Crescita Therapeutics Inc. (TSX:CTX)

Market Cap	14.71M +36.9%
Revenue (ttm)	23.22M +28.1%
Net Income	-320.00K
EPS	-0.02
Shares Out	18.61M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,164
Open	0.7900
Previous Close	0.7900
Day's Range	0.7900 - 0.7900
52-Week Range	0.4000 - 0.7900
Beta	-0.12
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Crescita Therapeutics

Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary drug delivery platforms, which include Multiplexed Molecular Penetration Enhancers and DuraPee that supports the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. The c...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Employees: 65
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: CTX

Financial Performance

In 2025, Crescita Therapeutics's revenue was 21.12 million, an increase of 7.85% compared to the previous year's 19.58 million. Losses were -92,000, -96.65% less than in 2024.